Benzinga | Aug 14, 2020 09:14AM EDT

Aptevo Therapeutics Q2 EPS $(2.10) Down From $(0.30) YoY, Sales $473.00K Down From $7.36M YoY

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(2.10) per share. This is a 600 percent decrease over losses of $(0.30) per share from the same period last year. The company reported $473.00 thousand in sales this quarter. This is a 93.57 percent decrease over sales of $7.36 million the same period last year.